Kurth T. The association of migraine with ischemic stroke. Curr Neurol Neurosci Rep. 2010;10:133–9. Important paper looking at the factors involved in migraine related stroke.
Bartleson JD, Cutrer FM. Migraine update. Diagnosis and treatment. Minn Med. 2010;93:36–41.
Stovner LJ, Zwart JA, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol. 2006;13:333–45.
Wang SJ. Epidemiology of migraine and other types of headache in Asia. Curr Neurol Neurosci Rep. 2003;3:104–8.
Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30:599–609.
Lipton RB, Hamelsky SW, Stewart WF. Epidemiology and impact of migraine. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff’s Headache and Other Head Pain. New York: Oxford University Press; 2001. p. 85–107.
Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30:1065–72.
Bigal ME, Lipton RB. Migraine at all ages. Curr Pain Headache Rep. 2006;10:207–13.
Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005;18:305–10.
Meyer JS, Terayama Y, Konno S, et al. Age-related cerebrovascular disease alters the symptomatic course of migraine. Cephalalgia. 1998;18:202–8.
Robertson WM, Welch KMA, Levine SL, Schultz LR. The effects of aging on cerebral blood flow in migraine. Neurology. 1989;39:947–51.
Aiba S, Tatsumoto M, Saisu A, et al. Prevalence of typical migraine aura without headache in Japanese ophthalmology clinics. Cephalalgia. 2010;30:962–7.
Kelman L. The Aura: a tertiary care study of 952 migraine patients. Cephalalgia. 2004;24:728–34.
Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24:1–160.
Silberstein S, Loder E, Diamond S, et al. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007;27:220–9.
Feleppa M, Bigal M, Lipton R. Headache in the elderly. Neurology. 2005;61 suppl 1:133–4.
Martins K, Bigal ME, Bordini CA, Speciali JG. Migraine in the elderly. Headache. 2006;46:312–6.
••Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology. 2006;67:246–51. A detailed examination of how migraine changes clinically with age across the lifespan.
Wöber-Bingöl Ç, Wöber C, Karwautz A, et al. Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine. Cephalalgia. 2004;24:12–7.
Rostrup E, Gouw AA, Vrenken H, et al. The spatial distribution of age-related white matter changes as a function of vascular risk factors—Results from the LADIS study. NeuroImage. 2012;60:1597–607.
Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia. 1991;11:69–74.
Murray ME, Vemuri P, Preboske GM, et al. A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. J Neuropathol Exp Neurol. 2012;71:1113–22.
••Turkoglu R, Tuzun E, Icor S, et al. Antineuronal antibodies in migraine patients with white matter lesions. Int Neurosci. 2011;121:33–6. First exploration of an uncharted area with significant implications.
Tisserand DJ, van Boxtel MP, Pruessner JC, et al. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cereb Cortex. 2004;14:966–73.
Rocca MA, Ceccarelli A, Falini A, et al. Brain gray matter changen migraine patients with T2-visible lesions A 3-T MRI study. Stroke. 2006;37:1765–70.
Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46:200–7.
Puente J, Jaque M, Carrasco C, et al. Triptan drugs, natural killer cell cytotoxicity, and neutrophils pro-matrix metalloproteinase-9 secretion. Headache. 2008;48:1482–9.
Vanhoutte PM, Scott-Burden T. The endothelium in health and disease. Tex Hear Inst J. 1994;21:62–7.
Bartley J. Could glial activation be a factor in migraine? J Med Hypotheses. 2009;72:255–7.
Bilbo SD, Smith SH, Schwarz JM. A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for Glia. J Neuroimmune Pharmacol. 2012;7:24–41.
Grinberg YY, Milton JG, Kraig RP. Spreading depression sends microglia on levy flights. PLoS One. 2011;6:e19294.
Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP. Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-α responses to spreading depression. J Neurochem. 2013. doi:10.1111/jnc.12267 [Epub ahead of print].
•Brown DR. Role of microglia in age-related changes to the nervous system. Sci World J. 2009;9:1061–71. Very comprehensive examination of the work done to date on microglia.
Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41:629–37.
Ebersberger A, Schaible H-G, Averbeck B, Richter F. Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache? Ann Neurol. 2001;49:7–13.
Durham PL, Garrett FG. Neurological mechanisms of migraine: potential of the gap junction modulator tonabersat in prevention of migraine. Cephalalgia. 2009;29 Suppl 2:1–6.
Wenk GL, Pierce DJ, Struble RG, Price DL, Cork LC. Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging. 1989;10:11–9.
Meltzer CC, Smith G, DeKosky ST, et al. Serotonin in aging, late-life depression, and alzheimer’s disease: the emerging role of functional imaging. Neuropsychopharmacology. 1988;18:407–30.
Glorioso C, Sibille E. Between destiny and disease: genetics and molecular pathways of human central nervous system aging. Prog Neurobiol. 2011;93:165–81.